Soluble LR11 associates with aortic root calcification in asymptomatic treated male patients with familial

Ranitha Vongpromek1, Sven Bos1, Gert-Jan R Ten Kate2

  • 1Department of Internal Medicine, Laboratory of Vascular Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.

Atherosclerosis
|June 23, 2017
PubMed

Insights

Soluble low-density lipoprotein receptor relative with 11 ligand-binding repeats (sLR11) is linked to aortic root calcification in male patients with familial hypercholesterolemia (FH). This finding may explain how atherosclerotic lesions distribute differently in FH vasculature.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Genetics

Background:

  • Familial hypercholesterolemia (FH) patients exhibit high vascular calcification rates despite statin therapy.
  • Cardiovascular disease risk factors include circulating soluble low-density lipoprotein receptor relative with 11 ligand-binding repeats (sLR11).

Purpose of the Study:

  • To investigate the association between plasma sLR11 levels and vascular calcification in asymptomatic, statin-treated heterozygous FH patients.

Main Methods:

  • 123 asymptomatic heterozygous FH patients (age 40-69) underwent CT scans for aortic root (ARC), aortic valve (AVC), and coronary artery calcification (CAC) scoring.
  • Plasma sLR11 levels were quantified using sandwich ELISA.

Main Results:

  • Positive correlation found between plasma sLR11 and ARC presence (r=0.2, p=0.03), but not AVC or CAC.
  • The sLR11-ARC association was significant in male FH patients (r=0.31, p=0.006).
  • Multivariate analysis confirmed sLR11 as an independent predictor of ARC (aOR=2.01, p=0.002).

Conclusions:

  • Plasma sLR11 is associated with aortic root calcification in male FH patients.
  • sLR11 may play a mechanistic role in the varied distribution of atherosclerotic lesions within the vasculature.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.6K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
649
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
516
Inflammation01:38

Inflammation

Overview
62.8K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
773
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
607